Key documents concerning Drug Consumption Rooms.
The INDCR will updates the library on a regular basis and delete outdated documents as soon as new ones are published.
Feel free to recommend/submit us texts to be added to the library.
DCR involvement in HCV prevention and treatment is crucial. So what is their response and where are the needs?
Uniting, Sydney and INDCR/Correlation Network published new report.
The report – based on an online survey under DCRs/SIFs worldwide – describes the range of services currently offered, the existing approaches to HCV awareness, prevention and treatment and what the needs are to improve and extend services.
The Sydney based Uniting Medically Supervised Injection Centre prepared an exhaustive, easy to read overview of scientific & grey literature that would facilitate scholars and advocates working in this area:
Overview of International Literature – Supervised Injecting Facilities & Drug Consumption Rooms (Issue 1: Aug 2017)
The document includes evidence of SIF/DCR effectiveness in regard of attracting high risk drug users, managing overdose and decrease overdose-related mortality, enhancing safe injecting practice, decreasing public drug use and improve public amenity and more.
Alternatives to Public Injection Harm Reduction Coalition, 2016
“With heroin cheap and widely available on city streets throughout the country, users are making their buys and shooting up as soon as they can, often in public places. Police officers are routinely finding drug users — unconscious or dead — in cars, in the bathrooms of fast-food restaurants, on mass transit and in parks, hospitals and libraries.”
Holly Catania took notes and wrote the original draft. Daniel Raymond, Policy Director and Sharon Stancliff, Medical Director, Harm Reduction Coalition wrote the introduction and the report was edited by Daniel Raymond, Sharon Stancliff and Benjamin Phillips. The convening was supported by Open Society Foundations and amfAR, The Foundation for AIDS Research.
Woods, S. (2014),
Organisational overview of drug consumption rooms in Europe, European Harm Reduction Network – Regenboog Groep, Amsterdam.
Drug Consumption Rooms in Europe
This report provides an overview of the organisation and working methods of drug consumption rooms (DCRs) in Europe It offers information about the functioning of DCRs as well as on the organisation and structure of such facilities and aims to benefit various groups of stakeholders.
In its discussion of aims, objectives, services, organisational structure and points of importance, the report is primarily directed at all who are involved in DCRs in Europe and beyond, or those who wish to set up a DCR in a new location. However, it may also be of interest to anyone concerned with the provision of basic services to drug users in Europe.
During the European Harm Reduction Conference and Network meeting in Amsterdam, a group of 15 representatives of drug consumption rooms agreed to coordinate efforts to improve information exchange and collaboration in order to support the work and establishment of DCR’ s in the world.
Client experience survey in Amsterdam and Rotterdam
This report summarises the results of a 2013 survey-based study focussing on the wellbeing and experiences of visitors to drug consumption rooms (DCRs) located in the Netherlands.
A 101-question survey on quality of life and DCR experience was administered to visitors attending three Amsterdam and one Rotterdam consumption room facilities. The purpose of this study is to develop and introduce a standardised data collection tool. As European data are limited, this report aims to establish a baseline for European consumption rooms.
Survey questions were used to gather data for two purposes:
PhD research examining the role low threshold harm reduction services play in the quality of life and wellbeing of people who use drugs, and
the development of a robust evaluation and guidance tool to be utilised across European DCRs.
Schäffer, D., Stöver, H. and Weichert, L. (2014),
Drug consumption rooms in Europe: models, best practice and challenges, European Harm Reduction Network, Amsterdam.
The report highlights the different models of drug consumption rooms in Europe, describes barriers for access, presents best practises and adressess in conclusion the advantages of DCRs for people who use drugs and for the general public.
Schatz, E., Nougier, M. (2012)
Drug consumption rooms Evidence and practice,
IDPC Briefing Paper
Hedrich, D., Kerr, T. and Dubois-Arber, F. (2010),
‘Drug consumption facilities in Europe and beyond’
Rhodes, T. and Hedrich, D. (eds),
Harm reduction: evidence, impacts and challenges,
EMCDDA Scientific Monograph Series No. 10, Publications Office of the European Union, Luxembourg, pp. 305–31.